Dodge & Cox holds 4.3% stake in GSK plc

Dodge & Cox, a California-based investment manager, reports on Amendment No. 3 to Schedule 13G that it beneficially owns 76,864,040 Ordinary Shares and 48,197,514 American Depositary Shares of GSK plc, representing 4.3% of this class.

Rhea-AI Filing Summary

Dodge & Cox, a California-based investment manager, reports on Amendment No. 3 to Schedule 13G that it beneficially owns 76,864,040 Ordinary Shares and 48,197,514 American Depositary Shares of GSK plc, representing 4.3% of this class. Dodge & Cox has sole voting power and sole dispositive power over all reported shares, with no shared voting or dispositive power, and confirms that its holdings are 5 percent or less of the class.

Key Figures

Ordinary Shares beneficially owned: 76,864,040 Ordinary Shares American Depositary Shares beneficially owned: 48,197,514 American Depositary Shares Percent of class owned: 4.3% +2 more

5 metrics

Ordinary Shares beneficially owned 76,864,040 Ordinary Shares Beneficially owned by Dodge & Cox as reported in Amendment No. 3

American Depositary Shares beneficially owned 48,197,514 American Depositary Shares Beneficially owned by Dodge & Cox as reported in Amendment No. 3

Percent of class owned 4.3% Percentage of the relevant GSK plc securities class held by Dodge & Cox

Sole voting power 74,703,040 Ordinary Shares; 46,407,039 ADSs Shares over which Dodge & Cox has sole power to vote or direct the vote

Sole dispositive power 76,864,040 Ordinary Shares; 48,197,514 ADSs Shares over which Dodge & Cox has sole power to dispose or direct disposition

Key Terms

Schedule 13G/A, beneficially owned, American Depositary Shares, sole power to vote or to direct the vote, +1 more

5 terms

Schedule 13G/A regulatory

"Dodge & Cox reports on Amendment No. 3 to Schedule 13G"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"Amount beneficially owned: 76,864,040 Ordinary Shares and 48,197,514 ADS"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

American Depositary Shares financial

"Title of class of securities: Ordinary Shares and American Depositary Shares"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

sole power to vote or to direct the vote financial

"Sole power to vote or to direct the vote: 74,703,040 Ordinary Shares"

sole power to dispose or to direct the disposition financial

"Sole power to dispose or to direct the disposition of: 76,864,040 Ordinary Shares"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of GSK (GSK) does Dodge & Cox report owning in this Schedule 13G/A?

Dodge & Cox reports beneficial ownership of 4.3% of the relevant GSK plc securities class. This percentage reflects combined holdings of Ordinary Shares and American Depositary Shares as disclosed in Amendment No. 3 to Schedule 13G.

How many GSK (GSK) Ordinary Shares does Dodge & Cox beneficially own?

Dodge & Cox beneficially owns 76,864,040 Ordinary Shares of GSK plc. These Ordinary Shares are held with sole voting and sole dispositive power, meaning Dodge & Cox alone directs how these shares are voted and disposed of.

How many GSK (GSK) American Depositary Shares does Dodge & Cox hold?

Dodge & Cox beneficially owns 48,197,514 American Depositary Shares of GSK plc. The firm has sole power to vote and dispose of all of these ADSs, with no reported shared voting or investment authority over them.

Does Dodge & Cox share voting or dispositive power over its GSK (GSK) holdings?

No. Dodge & Cox reports 0 shares with shared voting power and 0 shares with shared dispositive power. All reported GSK Ordinary Shares and ADSs are under its sole voting and sole dispositive authority, indicating centralized control.

Is Dodge & Cox’s ownership of GSK (GSK) above or below 5% of the class?

Dodge & Cox states its ownership is 5 percent or less of the relevant class, with a reported stake of 4.3%. This level is significant but remains below the 5% threshold often referenced for larger beneficial ownership positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 04:40 PM Accepted by SEC EDGAR 08/13/2026 - 04:40 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

GSK plc

(Name of Issuer)

Ordinary Shares and American Depositary Shares

(Title of Class of Securities)

37733W204

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 37733W204

1

Names of Reporting Persons

Dodge & Cox

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CALIFORNIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 167,517,118.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 173,259,068.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

173,259,068.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.3 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: GSK plc
(b)	Address of issuer's principal executive offices: 79 New Oxford Street, London, WC1A 1DG, United Kingdom
Item 2.
(a)	Name of person filing: Dodge & Cox
(b)	Address or principal business office or, if none, residence: 555 California Street 40th Floor, San Francisco, CA 94104
(c)	Citizenship: California, USA
(d)	Title of class of securities: Ordinary Shares and American Depositary Shares
(e)	CUSIP No.: 37733W204
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 76,864,040 Ordinary Shares and 48,197,514 American Depositary Shares
(b)	Percent of class: 4.3 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 74,703,040 Ordinary Shares and 46,407,039 American Depositary Shares
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 76,864,040 Ordinary Shares and 48,197,514 American Depositary Shares
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dodge & Cox

Signature:	/S/ Katherine M. Primas
Name/Title:	Chief Compliance Officer
Date:	08/13/2026